FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
Yad Vashem identifies 5 million Holocaust victims, with AI potentially recovering 250,000 more names from millions of documents.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
Yad Vashem identifies 5 million Holocaust victims, with AI potentially recovering 250,000 more names from millions of documents.